TMEM62: A Potential Drug Target and Biomarker for Various Diseases

Target Name: TMEM62

NCBI ID: G80021

TMEM62

TMEM62: A Potential Drug Target and Biomarker for Various Diseases

TMEM62 (Tissue Membrane-Associated EGFR-62) is a protein that is expressed in various tissues and is known for its role in cell signaling. TMEM62 has been identified as a potential drug target and a biomarker for various diseases, including cancer.

TMEM62 is a member of the EGFR family of transmembrane proteins, which are involved in cell signaling. The EGFR gene encodes a 21-kDa protein that is involved in the formation of the extracellular matrix (ECM) and in the regulation of cell growth and differentiation. The EGFR gene has four splice variants, including TMEM62, which is the most abundant variant.

TMEM62 is a protein that is expressed in various tissues, including the brain, heart, lungs, and gastrointestinal tract. It is also expressed in various types of cancer, including lung, breast, and ovarian cancer. TMEM62 has been shown to be involved in cell signaling, including the regulation of cell growth, differentiation, and survival.

One of the most promising aspects of TMEM62 is its potential as a drug target. TMEM62 has been shown to be involved in the regulation of various cellular processes, including cell growth, differentiation, and survival. This makes it an attractive target for small molecules, including anti-cancer drugs.

In addition to its potential as a drug target, TMEM62 has also been identified as a biomarker for various diseases, including cancer. TMEM62 has been shown to be expressed in various types of cancer, including lung, breast, and ovarian cancer. This makes it a potential biomarker for these diseases and could be used for the development of new diagnostic tests and therapies.

TMEM62 has also been shown to be involved in the regulation of various signaling pathways, including the TGF-β pathway. The TGF-β pathway is a well-established pathway that is involved in the regulation of cell growth, differentiation, and survival. TMEM62 has been shown to be involved in the regulation of TGF-β signaling, which suggests that it may be a useful target for drugs that are designed to inhibit TGF-β signaling.

In conclusion, TMEM62 is a protein that has been identified as a potential drug target and biomarker for various diseases. The EGFR family of proteins, including TMEM62, plays an important role in cell signaling and has been shown to be involved in the regulation of various cellular processes. Further research is needed to fully understand the potential of TMEM62 as a drug target and biomarker.

Protein Name: Transmembrane Protein 62

The "TMEM62 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TMEM62 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets